Screener

Eligibility screening

Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease

Sponsored by Bristol-Myers SquibbStudy detailsClinicalTrials.gov

28 US sites in CA, CO, DC, FL +13

Before we begin

Who are you filling this out for?

Your answer affects how the questions are phrased.